Organigram Global Inc 6-K, filed May 15, 2023
Organigram Global Inc. (OGI)
6-K
2023-05-15
For: 2023-05-12
View Original
Added on
April 11, 2026
About this 6-K
Organigram Global Inc filed this 6-K on May 15, 2023.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of May 2023
Commission File Number: 001-38885
ORGANIGRAM HOLDINGS INC.
(Translation of registrant’s name into English)
333 Bay Street, Suite 1250
Toronto, Ontario, Canada M5H 2R2
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F [ ] Form 40-F [ X ]
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): [ ]
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): [ ]
SUBMITTED HEREWITH
Exhibits
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.
ORGANIGRAM HOLDINGS INC.
/s/ Derrick West
Derrick West
Chief Financial Officer
Date: May 12, 2023
Exhibit 99.1
NOTICE OF CHANGE IN YEAR-END
PURSUANT TO SECTION 4.8 OF NATIONAL INSTRUMENT 51-102
ORGANIGRAM HOLDINGS INC.
|
1.
|
Change in Financial Year-End
|
Notice is hereby provided pursuant to section 4.8 of National Instrument 51-102 Continuous Disclosure Obligations (“NI 51-102”)
that Organigram Holdings Inc. (the “Issuer”) has decided to change its financial year end from August 31 to September 30.
|
2.
|
Reason for the Change
|
The change is being undertaken by the Issuer on the basis that it will better align the Issuer’s
financial statement reporting requirements with other public companies and calendar quarters.
|
3.
|
Relevant Dates for Financial Reporting Purposes
|
|
(a)
|
The Issuer’s old financial year-end was August 31.
|
|
(b)
|
The Issuer’s new financial year-end will be September 30.
|
|
(c)
|
The Issuer’s transition year will be the 13-month period ending September 30, 2023.
|
|
4.
|
The length and ending date of the periods, including the comparative periods and filing deadlines, of the interim and annual
financial statements to be filed for the Issuer’s transition year and its new financial year-end are as follows:
|
|
(a)
|
Transition Year - (September 1, 2022 to September
30, 2023)
|
|
Period and Ending Date
|
Length
|
Filing Deadlines
|
Comparative Period
and Ending Date |
|
First quarter interim financial statements for the period ended November 30, 2022
|
3 months
|
January 14, 2023
|
3 months ended
November 30, 2021 |
|
Second quarter interim financial statements for the period ended February 28, 2023
|
6 months
|
April 14, 2023
|
6 months ended
February 28, 2022 |
|
Third quarter interim financial statements for the period ended May 31, 2023
|
9 months
|
July 15, 2023
|
9 months ended
May 31, 2022 |
|
Annual
financial statements for the year ended September 30,
2023 (i.e., for the 13-months ended September 30, 2023)
|
13 months
|
December 29, 2023
|
12 months ended
August 31, 2022 |
|
(b)
|
New Financial Year - (October 1, 2023 to September 30, 2024)
|
|
Period and Ending Date
|
Length
|
Filing Deadlines
|
Comparative Period
and Ending Date |
|
First quarter interim financial statements for the period ended December 31, 2023
|
3 months
|
February 14, 2024
|
3 months ended
November 30, 2022 |
|
Second quarter interim financial statements for the period ended March 31, 2024
|
6 months
|
May 15, 2024
|
6 months ended
February 28, 2023 |
|
Third quarter interim financial statements for the period ended June 30, 2024
|
9 months
|
August 14, 2024
|
9 months ended
May 31, 2023 |
|
Annual financial statements for the year ended September 30, 2024
|
12 months
|
December 29, 2024
|
13 months ended
September 30, 2023 |
|
5.
|
The filing deadlines, prescribed under sections 4.2 and 4.4 of NI 51-102, for the interim and annual financial statements for the
Issuer’s transition year are as set forth under item 4 above.
|